Biofi lms can be defi ned as communities of microorganisms attached to a surface. Those bacterial biofi lms cause serious problems, such as antibiotic resistance and medical devicerelated infections. Nontypeable Haemophilus infl uenzae (NTHi) is an important pathogen in respiratory infections, as it forms biofi lms both in vitro and in vivo such as human middle ear. Recent reports indicate that otitis media, paranasal sinusitis and lower respiratory tract infections caused by Haemophilus infl uenzae have become more diffi cult to treat with oral antibiotic therapy. However, there has been no attention given to antibiotic eradication of NTHi biofi lm. To investigate the antimicrobial effect of various antibiotics against NTHi biofi lm formation, we conducted the following comparative study using both β -lactamase-negative ampicillin (AMP)-susceptible (BLNAS) and AMP-resistant (BLNAR) NTHi strains. In a microtiter biofi lm assay, both levofl oxacin and gatifl oxacin, of the fl uoroquinolone antibiotic group, signifi cantly inhibited biofi lm formation by BLNAS and BLNAR NTHi in a dose-dependent fashion compared to ampicillin of the penicillin antibiotic group, cefotaxime of the cephalosporin antibiotic group, and both erythromycin and clarithromycin of the macrolide antibiotic group. Furthermore, in fl ow cell chamber studies, confocal laser scanning microscopy counted survival bacteria in mature biofi lm had been treated with gatifl oxacin, ampicillin, cefotaxime and erythromycin. Only gatifl oxacin completely killed the BLNAR NTHi isolates within biofi lms without regard to the thickness of biofi lm formation. The results of this study suggest that fl uoroquinolones potentially have a role in therapy against diseases caused by both BLNAS and BLNAR NTHi isolates within biofi lms.